New oral tablets for bone health tested against injections
Knowledge-focused
Completed
This early-stage study tested several new oral tablet versions of a bone-building hormone (hPTH(1-34)) in 45 healthy men aged 18-35. The goal was to see how well the body absorbs these new tablets compared to an existing oral tablet and a standard injection. The study focused on …
Phase: PHASE1 • Sponsor: Entera Bio Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC